ZYMERON CORPORATION
- DURHAM, NC 27709
- zymeron.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $11M
- Awards on record
- 7
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
ZYMERON CORPORATION has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About ZYMERON CORPORATION
- Headquarters
- DURHAM, NC 27709
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIGAMMMRQ6QMN1
- CAGE7MVB7
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $11M
- Awards on record
- 7
- Top funding agencies
- Defense Health Agency · National Institutes of Health · Department of the Army
Awards
HT942524C0057
Recompete 6–12 mo: Potential end Jul 19, 2027 (8 months away)DHA SBIR DIRECT PHASE II H2D-0243 RAPID SAMPLE PROCESSING DEVICE TO SUPPORT BATTLEFIELD WOUND INFECTION DIAGNOSTICS
Department of Defense · Defense Health Agency
- Obligated
- $3M
- Period of performance
- Sep 20, 2024 – Jul 19, 2027
W81XWH22C0012
Completed: Period of performance ended Jun 6, 2026AWARD OF ZYMERON'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "DEVELOPMENT FOR A NOVEL COUNTERMEASURE, RADIODEFENDER, AS A RADIOPROTECTOR…
Department of Defense · Defense Health Agency
- Obligated
- $3M
- Period of performance
- Feb 7, 2022 – Jun 6, 2026
HT942523C0067
Completed: Period of performance ended Jan 14, 2026DHA SBIR DIRECT TO PH II MEDICAL R&D CONTRACT AWARDED FROM PROPOSAL NO.-H2D-0119 FOR "DEVELOPMENT FOR SHOCKDEFENDER AGAINST HEMORRHAGIC…
Department of Defense · Defense Health Agency
- Obligated
- $3M
- Period of performance
- Sep 15, 2023 – Jan 14, 2026
HT942524P0034
Completed: Period of performance ended Sep 15, 2024DHA STTR PHASE 1 MEDICAL RESEARCH AND DEVELOPMENT PURCHASE ORDER FOR "PROPOSAL H23C-002-0028 "DEVELOPMENT OF WOUNDSHIELD FOR PSEUDOMONAS…
Department of Defense · Defense Health Agency
- Obligated
- $250K
- Period of performance
- Feb 16, 2024 – Sep 15, 2024
W911QY24P0008
Completed: Period of performance ended Jun 13, 2024RESEARCH AND DEVELOPMENT
Department of Defense · Department of the Army
- Obligated
- $197K
- Period of performance
- Dec 14, 2023 – Jun 13, 2024
75N93021C00035
Completed: Period of performance ended Mar 15, 2024RAPID POINT OF CARE TESTS TO SIMULTANEOUSLY QUANTIFY ANTI-TB DRUGS IN BLOOD.
Department of Health and Human Services · National Institutes of Health
- Obligated
- $1.3M
- Period of performance
- Aug 12, 2021 – Mar 15, 2024
HT942523P0041
Completed: Period of performance ended Jan 29, 2024ZYMERON DHA SBIR PHASE I H231-004-0023 NOVEL AEROSOL THERAPY FOR IMMEDIATE AND SUSTAINED ARDS MANAGEMENT
Department of Defense · Defense Health Agency
- Obligated
- $250K
- Period of performance
- Jun 30, 2023 – Jan 29, 2024
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
HT942524C0057 DHA SBIR DIRECT PHASE II H2D-0243 RAPID SAMPLE PROCESSING DEVICE TO SUPPORT BATTLEFIELD WOUND INFECTION DIAGNOSTICS | Department of Defense · Defense Health Agency | 541715 · AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $3M | Sep 20, 2024 – Jul 19, 2027 | Recompete 6–12 mo: Potential end Jul 19, 2027 (8 months away)AI brief for award HT942524C0057Bid team for the recompete of award HT942524C0057 |
W81XWH22C0012 AWARD OF ZYMERON'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "DEVELOPMENT FOR A NOVEL COUNTERMEASURE, RADIODEFENDER, AS A RADIOPROTECTOR… | Department of Defense · Defense Health Agency | 541715 · AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $3M | Feb 7, 2022 – Jun 6, 2026 | Completed: Period of performance ended Jun 6, 2026 |
HT942523C0067 DHA SBIR DIRECT TO PH II MEDICAL R&D CONTRACT AWARDED FROM PROPOSAL NO.-H2D-0119 FOR "DEVELOPMENT FOR SHOCKDEFENDER AGAINST HEMORRHAGIC… | Department of Defense · Defense Health Agency | 541715 · AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $3M | Sep 15, 2023 – Jan 14, 2026 | Completed: Period of performance ended Jan 14, 2026 |
HT942524P0034 DHA STTR PHASE 1 MEDICAL RESEARCH AND DEVELOPMENT PURCHASE ORDER FOR "PROPOSAL H23C-002-0028 "DEVELOPMENT OF WOUNDSHIELD FOR PSEUDOMONAS… | Department of Defense · Defense Health Agency | 541715 · AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $250K | Feb 16, 2024 – Sep 15, 2024 | Completed: Period of performance ended Sep 15, 2024 |
W911QY24P0008 RESEARCH AND DEVELOPMENT | Department of Defense · Department of the Army | 541714 · AJ11GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH | $197K | Dec 14, 2023 – Jun 13, 2024 | Completed: Period of performance ended Jun 13, 2024 |
75N93021C00035 RAPID POINT OF CARE TESTS TO SIMULTANEOUSLY QUANTIFY ANTI-TB DRUGS IN BLOOD. | Department of Health and Human Services · National Institutes of Health | 541714 · AN14HEALTH R&D SERVICES; HEALTH CARE SERVICES; R&D ADMINISTRATIVE EXPENSES | $1.3M | Aug 12, 2021 – Mar 15, 2024 | Completed: Period of performance ended Mar 15, 2024 |
HT942523P0041 ZYMERON DHA SBIR PHASE I H231-004-0023 NOVEL AEROSOL THERAPY FOR IMMEDIATE AND SUSTAINED ARDS MANAGEMENT | Department of Defense · Defense Health Agency | 541715 · AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $250K | Jun 30, 2023 – Jan 29, 2024 | Completed: Period of performance ended Jan 29, 2024 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 42 awards
- Total awarded
- $24,710,238
- By phase
- SBIR Phase I: 28
- SBIR Phase II: 8
- STTR Phase I: 5
- STTR Phase II: 1
- By agency
- Department of Defense: 22
- Department of Health and Human Services: 19
- Department of Energy: 1
- Active projects
- 1 project
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 1 project
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2024: 4
- 2023: 4
- 2022: 5
- 2021: 10
- 2020: 7
- 2019: 7
- 2018: 3
- 2017: 2
Awards (most recent first)
Rapid Sample Processing Device to Support Battlefield Wound Infection Diagnostics
SBIR Phase II · Department of Defense (Defense Health Agency) · 2024 · $2,999,983
Sep 12, 2024 – Jan 19, 2027
- Direct to Phase II
- Active
- Ends Jan 2027
Solicitation 24.4 (2024) · Topic DHA244-D001
Development of WoundShield for Pseudomonas aeruginosa-Caused Wounds Infections
STTR Phase I · Department of Defense (Defense Health Agency) · 2024 · $249,995
Feb 13, 2024 – Sep 15, 2024
Solicitation 23.C (2023) · Topic DHA23C-002 · Research partner: University of Maryland, College Park
Omnidetect: a multiplexed portable detection platform enables culture-free enrichment and amplification to detect all types of foodborne pathogens
STTR Phase I · Department of Defense (Army) · 2024 · $197,000
Dec 12, 2023 – Jun 13, 2024
Solicitation 23.B (2023) · Topic A23B-T024 · Research partner: University of Massachusetts Amherst
An Automated Blood-in, miRNAs-out Assay to Detect Circulating and Exosome miRNAs
STTR Phase I · Department of Defense (Defense Health Agency) · 2024 · $250,000
Oct 5, 2023 – May 5, 2024
Solicitation 23.B (2023) · Topic DHA23B-001 · Research partner: North Carolina State University
Development for ShockDefender against Hemorrhagic Shock
SBIR Phase II · Department of Defense (Defense Health Agency) · 2023 · $2,999,999
Sep 14, 2023 – Jan 14, 2026
- Direct to Phase II
Solicitation 23.4 (2023) · Topic DHA234-D001
Advanced portable low temperature plasma device for chronic wound disinfection and healing
SBIR Phase I · Department of Energy · 2023 · $200,000
Jul 10, 2023 – Apr 9, 2024
Solicitation DE-FOA-0002903 (2023) · Topic C56-31a
Novel Aerosol Therapy for Immediate and Sustained ARDS Management
SBIR Phase I · Department of Defense (Defense Health Agency) · 2023 · $250,000
Jun 21, 2023 – Jan 29, 2024
Solicitation 23.1 (2023) · Topic DHA231-004
RAPID POINT OF CARE TEST TO SCREEN HUMAN PAPILLOMAVIRUS IN LOW-RESOURCE SETTINGS
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2023 · $13,720
Solicitation PHS-2023-1 (2022) · Topic 451
Lab-on-Chip Microfiltering and Imaging Device for Rapid and Automated Sterility Testing
SBIR Phase II · Department of Defense (Defense Advanced Research Projects Agency) · 2022 · $1,491,568
Aug 26, 2022 – Aug 26, 2025
Solicitation HR001120S0019.I (2020) · Topic HR001120S0019-27
Novel Antibiotics Targeting Multidrug-Resistant Pseudomonas Aeruginosa Infections
SBIR Phase II · Department of Defense (Defense Health Agency) · 2022 · $1,100,000
Jul 6, 2022 – Nov 10, 2024
Solicitation 21.1 (2021) · Topic DHA211-008
Small Molecule Therapeutics Targeting Members of the Bunyavirales Order
SBIR Phase I · Department of Defense (Office for Chemical and Biological Defense) · 2022 · $167,495
Mar 16, 2022 – Aug 31, 2022
Solicitation 21.2 (2021) · Topic CBD212-006
Development for a novel countermeasure, RadioDefender, as a radioprotector for hematopoietic acute radiation syndrome
SBIR Phase II · Department of Defense (Defense Health Agency) · 2022 · $2,999,993
Feb 7, 2022 – Jun 6, 2024
Solicitation 00.1 (2020) · Topic DHA201-002
SBIR TOPIC 441.ZYMERON WILL DEVELOP USER-FRIENDLY TECHNOLOGIES AND DEVICES TO CREATE AN AT-HOME HEPATITIS C VIRUS TEST.
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2022 · $400,000
Solicitation PHS-2022-1 (2021) · Topic 441
Novel Antibiotic Targeting Multidrug-Resistant Pseudomonas Aeruginosa Infections
SBIR Phase I · Department of Defense (Defense Health Agency) · 2021 · $249,999
Jul 26, 2021 – Feb 25, 2022
Solicitation 21.1 (2021) · Topic DHA211-008
Lab-on-Chip Microfiltering and Imaging Device for Rapid and Automated Sterility Testing
SBIR Phase I · Department of Defense (Defense Advanced Research Projects Agency) · 2021 · $224,999
May 10, 2021 – Jul 15, 2022
Solicitation HR001120S0019.I (2020) · Topic HR001120S0019-27
Long Lasting Drug Implants for Malaria Chemoprophylaxis
STTR Phase II · Department of Defense (Army) · 2021 · $1,099,999
Feb 22, 2021 – Jun 21, 2023
Solicitation 18.B (2018) · Topic A18B-T022 · Research partner: University of Georgia
Large Area Opioid Identification by Bioengineered Broad-Spectrum Receptors
STTR Phase I · Department of Defense (Office for Chemical and Biological Defense) · 2021 · $167,497
Jan 8, 2021 – Jun 10, 2021
Solicitation 20.A (2020) · Topic CBD20A-T001 · Research partner: Trustees of the University of Pennsylvania
THE OBJECTIVE OF THIS CONTRACT IS TO DESIGN, SYNTHESIZE COMPOUNDS THAT BIND TO NEF, AN HIV ACCESSORY PROTEIN.
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2021 · $300,000
Solicitation PHS2021-1 (2020) · Topic 88
THE CONTRACTOR SHALL DEVELOP A NOVEL NANOPARTICLE DELIVERY SYSTEM TO ELICIT POTENT AND LONG-LASTING ANTIBODY RESPONSE AND BROADLY NEUTRALIZING ACTIVIT
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2021 · $300,000
Solicitation PHS2021-1 (2020) · Topic 89
THE CONTRACTOR SHALL PROPOSE NOVEL, LOW-COST, REAL-TIME POINT-OF-CARE (POC) ASSAYS FOR HIV VIRAL LOAD MONITORING, HIV DRUG RESISTANCE MONITORING, AND
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2021 · $299,988
Solicitation PHS2021-1 (2020) · Topic 87
RAPID POINT OF CARE TESTS TO SIMULTANEOUSLY QUANTIFY ANTI-TB DRUGS IN BLOOD.
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2021 · $1,500,000
Solicitation PHS2019-1 (2018) · Topic 74
ORODISPERSIBLE FILM OF SECOND LINE DRUG FOR PEDIATRIC TUBERCULOSIS TREATMENT.
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2021 · $300,000
Solicitation PHS2021-1 (2020) · Topic 97
RAPID POINT OF CARE TESTS TO QUANTIFY HEPATITIS C VIRUS
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2021 · $300,000
Solicitation PHS2021-1 (2020) · Topic 99
Prophylactics for Ionizing Radiation-induced Hematopoietic Subsyndrome of ARS
SBIR Phase I · Department of Defense (Defense Health Agency) · 2020 · $249,992
Sep 24, 2020 – Apr 23, 2021
Solicitation 20.1 (2020) · Topic DHA201-002
Immediate Decontamination Kit for Military Working Dogs in Fields
SBIR Phase I · Department of Defense (Office for Chemical and Biological Defense) · 2020 · $167,494
Jan 28, 2020 – Jul 27, 2020
Solicitation 19.2 (2019) · Topic CBD192-001
Showing the 25 most recent of 42 awards.
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)Primary
- 541713Research and Development in NanotechnologySmall business under this code’s size standard
- 541714Research and Development in Biotechnology (except Nanobiotechnology)Small business under this code’s size standard
SAM.gov reports this entity as small under 2 of 3 NAICS codes. Size is determined per code (SBA size standards).
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with ZYMERON CORPORATION?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.